ATOMO DIAGNOSTICS LIMITED (AT1)

---

AI Coverage Rating: Active

ASX AI Signals has generated 4 signal for AT1 during the last 90 days, indicating active trading activity and ongoing AI monitoring

Latest AT1 Signals
11/06/2026	SELL
05/06/2026	SELL
20/05/2026	SELL
AT1 Share Price
Current Price	$0.018
52 Week High	$0.044
52 Week Low:	$0.014
Trading at (% of 52 Week High)	40.91%

Business Overview

Atomo Diagnostics Limited (ASX: AT1) is an Australian company that develops and manufactures rapid diagnostic testing devices. Their products are designed for simple, accurate, and fast point-of-care testing, primarily targeting infectious diseases and health conditions. The company's technology aims to improve healthcare delivery by providing easy-to-use testing solutions outside traditional laboratory settings.

ASX Sector Overview

Sector:   Health Care Equipment & Services

The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.

Latest AI Recommendation

The SELL recommendation for ATOMO DIAGNOSTICS LIMITED is supported by weak price performance and potential liquidity concerns at the current low price level. However, the confidence is moderated by limited available fundamental data and market volatility.

Latest  ATOMO DIAGNOSTICS LIMITED(AT1)   News